Skip to main content
OpenTrials
Completed

NCT Number: NCT04845776

Vitamin/Mineral Supplement for Children With Autism

This is an open-label 3 month clinical trial of a vitamin/mineral supplement designed for children with autism.

Completed

Looking for future studies?

Notify Me

Key information

Age range

3 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Arizona State University

Tempe, Arizona, 85287, United States

About this study

This is an open-label 3 month clinical trial of a vitamin/mineral supplement designed for children with autism. There will be pre/post assessments of autism symptoms,GI symptoms, and laboratory tests. Typically-developing children will be assessed at baseline only (no treatments) for comparison.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Child age 3-17 years (up until 18th birthday)
  • Previous diagnosis of ASD by a psychiatrist, psychologist, or developmental pediatrician
  • Verification of diagnosis by ASU staff using the Autism Diagnostic Interview-Revised.
  • No changes in any medical, nutritional, dietary, behavior, or other treatment in the last three months, and a willingness to avoid any changes during the study
  • Participant is able to wear a mask during the short visit for the blood draw.

Exclusion criteria

  • Parent/guardian is unable to read or speak English fluently.
  • Use of a vitamin/mineral supplement in the past 3 months
  • Previous adverse reaction to a vitamin/mineral supplement
  • Unstable, poor health; seizure disorder that is not responsive to treatment or not on stable management or complex type; or other health conditions that would significantly increase their risk of adverse effects (per physician clinical judgement)
  • Use of any medication which has a contra-indication for one of the ingredients in the vitamin/mineral supplement
  • A major single-gene disorder such as Fragile X, Down's Syndrome.
  • Major brain malformation
  • Tube feeding
  • Current participation in other clinical trials
  • Females who are pregnant or who are sexually active without effective birth control.
  • Clinically significant abnormalities at baseline on two blood safety tests: Comprehensive Metabolic Panel and Complete Blood Count with Differential.
  • Psychotropic medication use which can affect neurotransmitter levels/function - Current or within past 2 months

Treatment and study plan

ANRC Essentials Plus

Dietary Supplement

a vitamin/mineral supplement designed for children and adults with autism

Primary outcomes

  1. Parent Global Impressions of Autism

    Time frame: assessed at the 3 months (end of treatment)

    a 20-item questionnaire with a Likert scale assessing changes in symptoms

Sponsors and collaborators

Lead sponsor

Arizona State University

Other

Collaborators

  • Southwest College of Naturopathic Medicine

Registry information

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Apr 15, 2021
Registry last updated
Jan 9, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.